Check out your Company Bowl for anonymous work chats.
We’re proud to be named one of the Best Companies for Women. Our long-term diversity strategy has seen gains in representation across the company. We strive to continue advancing our ambitious 2025 Diversity & Inclusion Commitments focused on advancing equality with concrete actions and results. View the full list here: https://www.diversitywoman.com/meet-the-companies-setting-the-standard-2/
We are thrilled to share our investment for the Community Health Justice Fund, a three-year, $6 million commitment to community based organizations. The objective is to implement transformative solutions to advance health equity and improve health and well-being for generations to come. Read more here:
We are thrilled to kick off the second year of our Genentech Leadership for Executive Advancement and Development (gLEAD) program with a new group of talented leaders. Our continuous focus on leadership development enables us to work together effectively and deliver groundbreaking science to benefit all patients. Learn more here:
Li Xiong, Staff Packaging Engineer and Team Lead at Genentech shares his journey of breaking barriers and finding his leadership path. Through the Asian Leadership Academy Program, Li learned more about leading a team while fostering a supportive community. Read more about how Li stepped out his comfort zone and embraced opportunities. #GenentechChangemakers
We had an amazing time hosting the AXIS Dance Company, an innovative dance company who are changing the way we think about the possibilities of the human body. Our employees were treated to a stunning performance that highlighted the importance of inclusion. Thank you AXIS for sharing incredible art with us and reminding us of the significance of creating a workplace where everyone feels a sense of belonging and can be their authentic selves every day.
Happy Earth Month! As a company, we are committed to reducing our environmental impact on the world. We designed our buildings with sustainability in mind along with other core values such as well-being, collaboration, and flexibility. Learn more about our sustainability commitments and ambitions.
We just launched our third annual 2022 D&I Report, which highlights the many efforts we have made toward achieving our Diversity and Inclusion goals. Learn more about the progress we have made across the three pillars for our 2025 D&I Commitments: Fostering Belonging, Advancing Inclusive Research & Health Equity, and Transforming Society.
Our global manufacturing network will have a second site in Oceanside that aims to produce biologics rapidly, efficiently, and sustainably for smaller patient populations. This expansion will assist us in fulfilling the increasing demand for top-notch medications and enable us to keep researching and developing life-altering treatments for patients globally.
#ICYMI In the finale episode of Two Scientists Walk Into a Bar, Lélia Delamarre, Director and Distinguished Scientist, Cancer Immunology, and Ina Rhee, Executive Group Medical Director, Oncology Early Clinical Development, discuss the science behind cancer vaccination and the current challenges and opportunities we are facing. Listen to the full podcast to learn more.
Today, health inequity remains a severe issue in our society. Patients from underrepresented groups are still less likely to receive quality health care. To tackle the root causes of healthcare discrepancies, we continue to ask bigger questions and strive to advance inclusive research.
